BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cacabelos R, Naidoo V, Corzo L, Cacabelos N, Carril JC. Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. IJMS 2021;22:13302. [DOI: 10.3390/ijms222413302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wolf U, Baust H, Neef R, Steinke T. Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy. Antibiotics 2022;11:1381. [DOI: 10.3390/antibiotics11101381] [Reference Citation Analysis]
2 Pop C, Cristina A, Iaru I, Popa SL, Mogoșan C. Nation-Wide Survey Assessing the Knowledge and Attitudes of Romanian Pharmacists Concerning Pharmacogenetics. Front Pharmacol 2022;13:952562. [DOI: 10.3389/fphar.2022.952562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Khasawneh LQ, Al-Mahayri ZN, Ali BR. Mendelian randomization in pharmacogenomics: The unforeseen potentials. Biomed Pharmacother 2022;150:112952. [PMID: 35429744 DOI: 10.1016/j.biopha.2022.112952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cacabelos R, Naidoo V, Martínez-iglesias O, Corzo L, Cacabelos N, Pego R, Carril JC. Personalized Management and Treatment of Alzheimer’s Disease. Life 2022;12:460. [DOI: 10.3390/life12030460] [Reference Citation Analysis]